CRIS Current Research Information System

CASTELLUCCI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.381
EU - Europa 6.029
AS - Asia 3.595
AF - Africa 437
SA - Sud America 39
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.327
GB - Regno Unito 1.729
CN - Cina 1.138
VN - Vietnam 1.098
DE - Germania 866
SE - Svezia 851
SG - Singapore 835
IT - Italia 761
RU - Federazione Russa 376
IN - India 316
UA - Ucraina 316
IE - Irlanda 274
FR - Francia 230
TG - Togo 154
FI - Finlandia 145
EE - Estonia 121
ZA - Sudafrica 113
CH - Svizzera 107
JO - Giordania 99
CI - Costa d'Avorio 97
BG - Bulgaria 80
CA - Canada 51
NG - Nigeria 46
BE - Belgio 37
IR - Iran 32
BR - Brasile 30
NL - Olanda 30
SC - Seychelles 22
AT - Austria 21
ES - Italia 20
JP - Giappone 13
HR - Croazia 12
ID - Indonesia 12
PL - Polonia 9
CZ - Repubblica Ceca 8
GR - Grecia 7
HK - Hong Kong 7
RO - Romania 7
TR - Turchia 7
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
AR - Argentina 4
BD - Bangladesh 4
HU - Ungheria 4
PT - Portogallo 4
AU - Australia 3
BJ - Benin 3
KR - Corea 3
LT - Lituania 3
MX - Messico 3
TH - Thailandia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
IQ - Iraq 2
KZ - Kazakistan 2
MN - Mongolia 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
IL - Israele 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
TN - Tunisia 1
Totale 18.487
Salva come PNG Salva come JPEG
Città #
Southend 1.575
Fairfield 934
Chandler 899
Ashburn 817
Singapore 720
Wilmington 449
Houston 446
Woodbridge 430
Seattle 411
Santa Clara 385
Cambridge 344
Princeton 341
Ann Arbor 279
Dublin 274
Dong Ket 234
Boardman 219
Jacksonville 214
Lomé 154
Westminster 149
Helsinki 138
Bologna 132
Padova 131
Nanjing 125
Berlin 110
Bern 100
Amman 99
Abidjan 97
Munich 96
New York 92
Beijing 88
Jinan 83
Shenyang 74
Sofia 74
Saint Petersburg 71
Turin 67
Florence 62
Hebei 52
Changsha 49
Bremen 48
Mülheim 47
Abeokuta 44
Redmond 44
San Diego 44
Milan 42
Nanchang 41
Tianjin 41
Guangzhou 38
Medford 38
Jiaxing 37
Los Angeles 37
Brussels 36
Redwood City 34
Zhengzhou 31
Toronto 30
Falkenstein 26
Dearborn 25
Shanghai 25
Norwalk 24
Des Moines 23
Yubileyny 22
Mahé 21
Frankfurt am Main 19
Haikou 18
Kuban 18
Falls Church 17
Hangzhou 17
Taiyuan 17
Taizhou 17
Ottawa 16
Ningbo 15
Olalla 15
Kunming 14
London 14
Nuremberg 14
Phoenix 13
Jakarta 12
Mountain View 12
Tokyo 12
Wuhan 12
Zanjan 12
Chicago 11
Amsterdam 10
Bühl 10
Lanzhou 10
Rome 10
Sacramento 10
San Venanzo 10
Barcelona 9
Vienna 9
Costa Mesa 8
Fuzhou 8
Hyderabad 8
Leawood 8
Shenzhen 8
Venezia 8
Verona 8
Xi'an 8
Buffalo 7
Hefei 7
Monmouth Junction 7
Totale 12.270
Salva come PNG Salva come JPEG
Nome #
Combined (18)F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer. 384
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. 241
18F-FDG PET early after radiotherapy in lymphoma patients. 240
11-C-choline PET/CT imaging for localization of recurrent prostate cancer 234
11 C-CHOLINE-PET/CT FOR PREOPERATIVE N-STAGING IN HIGH RISK PROSTATE CANCER 194
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 182
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 180
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. 176
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 176
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 173
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 173
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 170
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 165
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 162
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 162
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 160
11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard 160
11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. 159
11C-CHOLINE PET/TC imaging for localization of recurrent prostate cancer 157
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? 155
11C-Choline PET/CT for Restaging of Bladder Cancer 153
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 149
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. 148
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 146
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 146
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 146
Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer 143
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer. 143
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 143
11C-choline PET/CT scan in patients with prostate cancer treated with intermittent ADT: a sequential PET/CT study. 142
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer 141
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 140
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 140
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 139
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 139
18 FDG-PET nel follow.up dei pazienti con carcinoma tiroideo differenziato 138
18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy. 138
PET-TC con 11C-colina e Spettroscopia di Risonanza Magnetica nella diagnosi e localizzazione del tumore prostatico: confronto con l'analisi seriata dello specimen chirurgico. 138
Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature 136
18f-fdg pet/ct for restaging gastric cancer after surgical resection 136
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy 136
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 135
11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer. 134
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation. 133
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 132
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL 131
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy. 130
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 130
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 130
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma 126
11C-methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results 126
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 125
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 124
Androgen deprivation therapy influences the uptake of 11C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study. 122
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 122
CT with 11C-Choline for identification of recurrent prostate cancer 121
Erratum to: Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. 121
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 120
Potential Prognostic Role of 18F-FDG PET/CT in Invasive Epithelial Ovarian Cancer Relapse. A Preliminary Study 120
null 119
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 118
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 118
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 117
EFFETTO DELLA TERAPIA ORMONALE SULLA CAPTAZIONE DI 11-C-COLINA IN PAZIENTI CON RIPRESA DI MALATTIA DA CARCINOMA PROSTATICO 116
Image fusione between PET and CT for radiotherapy treatment planning for head and neck cancer 116
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 116
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 114
Current Application and Future Perspectives of Prostate Specific Membrane Antigen PET Imaging in Prostate Cancer 114
Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer 113
null 113
Restaging Clear Cell Renal Carcinoma With 18F-FDG PET/CT. 112
Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer. 112
The role of 11C-choline PET imaging in the early detection of recurrence in surgically treated prostate cancer patients with very low PSA level <0.5 ng/mL. 111
Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy 111
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial 111
A Rare Case of Epididymal Metastasis After Radical Prostatectomy Detected by 68Ga-PSMA PET/CT. 111
PET/TC CON 11-C-COLINA E SPETTROSCOPIA DO RISONANZA MAGNETICA NELLA DIAGNOSI E LOCALIZZAZIONE DEL TUMORE PROSTATICO: CONFRONTO CON LA ANALISI SERIATA DELLO SPICIMEN CHIRURGICO 110
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 109
Choline PET/CT for prostate cancer: Main clinical applications. 109
Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer. 108
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 107
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection. 106
Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy? 106
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA 106
Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis. 105
Imaging with (11)Carbon labelled PET tracers. 104
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 104
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 103
PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications 103
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 103
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 101
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 101
Comparative imaging evaluation before surgical resection of liver metastasis in colorectal cancer patients. First results of Italian Prometeo study 101
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL. 101
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. 101
SEXTANT LOCALIZATION OF PROSTATE CANCER WITH 11C-CHOLINE PET/CT: COMPARISON WITH THREE-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING USING STEP SECTION HISTOPATHOLOGY AS STANDARD OF REFERENCES 100
C–CHOLINE PET/CT IMAGING IS USEFUL FOR METASTATIC LYMPH NODES DETECTION IN NEWLY DIAGNOSED PROSTATE CANCER 100
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence. 100
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 99
Positron-emission tomography in gynaecologic malignancies. 99
Totale 13.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020696 0 0 0 0 0 0 0 0 0 255 215 226
2020/20212.228 461 129 75 82 38 116 36 181 279 87 128 616
2021/20223.598 892 89 188 295 286 139 57 193 100 181 701 477
2022/20233.781 361 546 232 477 237 293 98 202 695 128 302 210
2023/20241.129 95 165 31 68 72 220 57 262 50 56 26 27
2024/20252.716 167 561 284 278 666 248 297 132 82 1 0 0
Totale 18.920